Newsbenzinga
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic’s Weight Loss in Late-Stage Diabetes Trial
· Published
Article summary
Lilly’s retatrutide delivered more than double Ozempic’s weight loss in head-to-head diabetes trial
An excerpt from the original article.
Comments —
Loading comments…